Healthcare Dec 30, 2020 05:28 PM (GMT+8) · EqualOcean
On December 30, 2020, according to the announcement of the State Administration of market supervision and administration, Jilin Maifu Nutrition Technology Co., Ltd. (hereinafter referred to as "Maifu nutrition technology") has officially obtained the registration approval of ty batch number, i.e. formula food for special medical purposes (i.e. "special medical food") on December 21, 2020 (batch number: national food) Note: ty20200013). This is the 57th approved special medical food so far and the 14th approved in 2020. Formula food for special medical purposes (special medical food) is specially processed and formulated to meet the special needs of people with limited eating, digestive and absorption disorders, metabolic disorders or specific diseases for nutrients or diet. Such products must be taken alone or in combination with other foods under the guidance of doctors or clinical nutritionists. In January 2016, Maifu nutrition was invested and established by Sihuan pharmaceutical holding group. It is a professional clinical nutrition solution provider and an international company integrating R & D, production, promotion and operation. Maifu nutrition is composed of Hainan Maifu nutrition Co., Ltd., Maifu nutrition technology (Beijing) Co., Ltd., Jilin Maifu nutrition Co., Ltd., Hong Kong Maifu nutrition Co., Ltd. and Beijing Maifu Medical Research Co., Ltd. The first phase of Maifu nutrition investment is 300 million yuan, which is used for the international authority of special medical food research and development center, production line construction and sales operation.

This text is a result of machine translation.